| Venetoclax and Irinotecan in Relapsed/Refractory SCLC (NCT04543916) | Virginia Commonwealth University | 2021-06-30 |
| Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide (NCT03509545) | Sarfez Pharmaceuticals, Inc. | 2021-06-30 |
| Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma (NCT04656431) | James Rubenstein | 2021-06-29 |
| First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML (NCT04840784) | Shengke Pharmaceuticals Pty Ltd | 2021-06-29 |
| (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC (NCT04862780) | Blueprint Medicines Corporation | 2021-06-29 |
| Study of IBI323 in Patients With Advanced Malignancies (NCT04916119) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-06-29 |
| Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy Volunteers (NCT04798222) | AstraZeneca | 2021-06-29 |
| Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors (NCT04900818) | I-Mab Biopharma US Limited | 2021-06-29 |
| Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects (NCT07588646) | Sunshine Lake Pharma Co., Ltd. | 2021-06-29 |
| A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL) (NCT04914741) | Peter MacCallum Cancer Centre, Australia | 2021-06-29 |
| Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE) (NCT04411654) | Prevail Therapeutics | 2021-06-29 |
| Safety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjects (NCT04951505) | Venatorx Pharmaceuticals, Inc. | 2021-06-29 |
| A Study of DZD2269 in Healthy Adult Participants (NCT04932005) | Dizal Pharmaceuticals | 2021-06-29 |
| MT1013 Clinical TRIAL In Healthy Subject (NCT04783090) | Shaanxi Micot Pharmaceutical Technology Co., Ltd. | 2021-06-28 |
| Phase I/II Study of FR104 First Administration In Patient With Renal Transplantation: FIRsT Study (NCT04837092) | Nantes University Hospital | 2021-06-28 |
| SPY Fluorescence Imaging Systems and Indocyanine Green to Determine the Percentage of Successful Critical Anatomy Recognition in Laparoscopic Cholecystectomy Surgeries. (NCT05006950) | Stryker Endoscopy | 2021-06-28 |
| Investigate the Safety, Tolerability and Pharmacokinetics of FBL-MTX (NCT05117593) | SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd | 2021-06-28 |
| Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC (NCT04846478) | Dana-Farber Cancer Institute | 2021-06-28 |
| A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors (NCT05291182) | Shouyao Holdings (Beijing) Co. LTD | 2021-06-28 |
| A Study to Assess an ATX Inhibitor (IOA-289) in Healthy Volunteers (NCT05027568) | iOnctura | 2021-06-28 |
| Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD) (NCT04931862) | Wave Life Sciences USA, Inc. | 2021-06-28 |
| A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer (NCT04870112) | AstraZeneca | 2021-06-28 |
| A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers (NCT04839042) | Moat Biotechnology Corporation | 2021-06-28 |
| Drug Interaction Between SHR4640 Tablets and Furosemide Tablets in Healthy Volunteers (Single Center, Single Arm, Open, Self-control) (NCT04850638) | Jiangsu HengRui Medicine Co., Ltd. | 2021-06-28 |
| Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients (NCT04935580) | Shanghai Changzheng Hospital | 2021-06-28 |
| A Trial to Learn How BAY1834845 and BAY1830839 Affect Inflammation When Taken by Mouth Twice a Day for 7 Days in a Row in Healthy Male Participants (NCT05003089) | Bayer | 2021-06-28 |
| A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease (NCT04971733) | Eisai Inc. | 2021-06-28 |
| Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer (NCT04725994) | Idience Co., Ltd. | 2021-06-28 |
| Wireless TENS for Peripheral Edema (Lower Limb Swelling) (NCT04680533) | University of Rochester | 2021-06-28 |
| A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib (NCT04959266) | AstraZeneca | 2021-06-28 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS (NCT05003388) | The Foundation for Orthopaedics and Regenerative Medicine | 2021-06-26 |
| A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease (NCT04944043) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-06-25 |
| A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer (NCT04718740) | Jiangsu HengRui Medicine Co., Ltd. | 2021-06-25 |
| A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants (NCT04941755) | Bristol-Myers Squibb | 2021-06-25 |
| A Bioequivalence Study of Hetrombopag in Healthy Subjects (NCT05088655) | Jiangsu HengRui Medicine Co., Ltd. | 2021-06-25 |
| Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azacitidine Subcutaneously or IV and Venetoclax Orally in Participants With Acute Myeloid Leukemia and With Azacitidine With or Without Venetoclax in Participants With Myelodysplastic Syndrome (NCT04912063) | AbbVie | 2021-06-25 |
| Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Infusion of XTMAB-16 in Healthy Adult Participants (NCT04971395) | Xentria, Inc. | 2021-06-25 |
| Phase I Clinical Trial of TQC2731 Injection (NCT04923607) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-06-25 |
| A Study to Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors (NCT05105464) | Shanghai Runshi Pharmaceutical Technology Co., Ltd | 2021-06-25 |
| Safety, Tolerability, and Pharmacokinetics of AB-836 in Healthy Subjects and Subjects With Chronic HBV Infection (NCT04775797) | Arbutus Biopharma Corporation | 2021-06-25 |
| Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors (NCT04866641) | Taivex Therapeutics Corporation | 2021-06-24 |
| A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer (NCT04999605) | Akeso | 2021-06-24 |
| Exenatide for Treating Cocaine Use Disorder (NCT04941521) | The University of Texas Health Science Center, Houston | 2021-06-24 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008 (NCT05050188) | Jiangsu Carephar Pharmaceutical Co., Ltd. | 2021-06-24 |
| A Study of the Safety and Tolerability of IBI321 in Patients With Advanced Solid Tumors (NCT04911881) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-06-24 |
| A Study to Evaluate Lu AG06466 in Participants With Fibromyalgia (NCT04974359) | H. Lundbeck A/S | 2021-06-24 |
| Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (NCT05103423) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2021-06-24 |
| Study of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy Volunteers (NCT04969497) | Zosano Pharma Corporation | 2021-06-24 |
| Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444 (NCT05009199) | Invicro | 2021-06-24 |
| A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]-JNJ-70099731 in Healthy Male Participants (NCT04911543) | Janssen Research & Development, LLC | 2021-06-23 |
| Phase I Clinical Study of HY01 in Patients (NCT04961099) | Heyu (Suzhou) Pharmaceutical Technology Co., Ltd | 2021-06-23 |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults in Good General Heath (NCT04794218) | International AIDS Vaccine Initiative | 2021-06-23 |
| Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy (NCT04827875) | AiViva BioPharma, Inc. | 2021-06-23 |
| To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers (NCT05383131) | Sunshine Lake Pharma Co., Ltd. | 2021-06-23 |
| VNRX-9945 Safety and Pharmacokinetics in Healthy Adult Volunteers (NCT04845321) | Venatorx Pharmaceuticals, Inc. | 2021-06-23 |
| VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma) (NCT04702425) | Novartis Pharmaceuticals | 2021-06-23 |
| Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults (NCT04840849) | AstraZeneca | 2021-06-22 |
| A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer (NCT04802759) | Hoffmann-La Roche | 2021-06-22 |
| Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema (NCT04894110) | Emmecell | 2021-06-22 |
| Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder (NCT03896516) | National Institute on Drug Abuse (NIDA) | 2021-06-22 |
| A Study to Evaluate the Pharmacokinetics，Safety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection (NCT04864743) | Hangzhou Gensciences Biopharmaceutical Co., Ltd. | 2021-06-22 |
| ALPN-202 With PD-1 Inhibition in Advanced Malignancies (NCT04920383) | Alpine Immune Sciences, Inc. | 2021-06-22 |
| Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors (NCT04840394) | Eikon Therapeutics | 2021-06-22 |
| A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN (NCT04973657) | Viking Therapeutics, Inc. | 2021-06-22 |
| A Study of Dose Escalation of IBI321 in Patients With Advanced Solid Tumors (NCT04911894) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-06-21 |
| Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC-PC) (NCT04615845) | Pharmicell Co., Ltd. | 2021-06-21 |
| The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers (NCT04742842) | University of Sydney | 2021-06-21 |
| A Single and Multiple Dose Study to Assess How the Drug Enters, Moves Through and Exits the Body, Safety and Tolerability of Safinamide in Healthy Adult Chinese Volunteers (NCT03887221) | Zambon SpA | 2021-06-21 |
| QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors (NCT04898543) | ImmunityBio, Inc. | 2021-06-21 |
| A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD (NCT04931459) | Acumen Pharmaceuticals | 2021-06-21 |
| Pharmacokinetics of GH001 in Healthy Volunteers (NCT05163691) | GH Research Ireland Limited | 2021-06-21 |
| SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma (NCT04923126) | St. Jude Children's Research Hospital | 2021-06-21 |
| Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial (NCT04652908) | University of California, Davis | 2021-06-21 |
| A Study to Evaluate the Drug Levels and Safety of Pegbelfermin in Healthy Overweight and Obese Chinese and Korean Participants (NCT04649710) | Bristol-Myers Squibb | 2021-06-21 |
| Prehabilitation, Rehabilitation and Comprehensive Approach to the Sequelae of Brain Tumors (NCT05844605) | Institut Guttmann | 2021-06-21 |
| To Evaluate the Comparative Pharmacokinetics of Orally Administered EQ143 in Different Racial and Ethnic Populations (NCT04969965) | EQRx, Inc. | 2021-06-21 |
| Ovarian Injection of PRP (Platelet -Rich Plasma) Vs Normal Saline in Premature Ovarian Insufficiency (NCT04922398) | Ahmed Saad | 2021-06-20 |
| Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012 (NCT05017987) | Autotelicbio | 2021-06-19 |
| A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors (NCT04861987) | Processa Pharmaceuticals | 2021-06-18 |
| Effects of Dimethyltryptamine in Healthy Subjects (NCT04353024) | University Hospital, Basel, Switzerland | 2021-06-18 |
| A Trial of AK117 (Anti-CD47) in Patients With Myelodysplastic Syndrome (NCT04900350) | Akeso | 2021-06-18 |
| FMT In High-Risk Acute GVHD After ALLO HCT (NCT04139577) | Massachusetts General Hospital | 2021-06-18 |
| Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS (NCT04810611) | Novartis Pharmaceuticals | 2021-06-18 |
| First-in-Human Study of VB0004 in Healthy Subjects and to Patients With Mild to Moderate Hypertension With Low Cardiovascular Risk (NCT04925050) | Syneos Health | 2021-06-17 |
| A Study of Guselkumab in Adult Participants With Celiac Disease (NCT04704843) | Janssen Research & Development, LLC | 2021-06-17 |
| A Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of THDB0206 Injection in Healthy Chinese Subjects (NCT06153329) | Tonghua Dongbao Pharmaceutical Co.,Ltd | 2021-06-17 |
| A Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Single Dose Vupanorsen In Healthy Chinese Adults (NCT04916795) | Pfizer | 2021-06-17 |
| Biodistribution and Dosimetry of 99mTc-Duramycin (NCT05177640) | University Hospital, Antwerp | 2021-06-17 |
| Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study) (NCT04715022) | University of Kansas Medical Center | 2021-06-17 |
| IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study) (NCT04294043) | Chris Goss | 2021-06-17 |
| MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer (NCT04808323) | Medical College of Wisconsin | 2021-06-17 |
| Safety Study of Cenobamate in Subjects With Normal Hepatic Function and Subjects With Severe Hepatic Impairment (NCT04791553) | SK Life Science, Inc. | 2021-06-17 |
| Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors (NCT05103631) | Baylor College of Medicine | 2021-06-17 |
| Food Intake and Intra-Nasal Insulin for African American Adults (FIINAAL) (NCT04739371) | Pennington Biomedical Research Center | 2021-06-17 |
| A Study to Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control Subjects (NCT04899219) | Idorsia Pharmaceuticals Ltd. | 2021-06-16 |
| A Study of JNJ-69095897 in Healthy Participants (NCT04920578) | Janssen Research & Development, LLC | 2021-06-16 |
| Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers (NCT06254235) | Qilu Pharmaceutical Co., Ltd. | 2021-06-16 |
| Sterile Amniotic Fluid Filtrate Epidural Injection. (NCT04537026) | University of Utah | 2021-06-16 |
| A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ，Fc Fusion Protein for Injection (NCT05251090) | Hangzhou Gensciences Biopharmaceutical Co., Ltd. | 2021-06-16 |
| Topotecan Episcleral Plaque for Treatment of Retinoblastoma (NCT04156347) | Targeted Therapy Technologies, LLC | 2021-06-16 |